Sophia Delicou: A Shift Toward Function-Centered Care for Patients with Hemoglobinopathies
Sophia Delicou, Head of Thalassemia and Sickle Cell Unit, Head of the Expertise Center of Hemoglobin Diseases and Their Complications at Hippokrateio General Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Mediterranean Journal of Hematology and Infectious Diseases, adding:
“New Publication Announcement!
I’m pleased to share our latest publication in the Mediterranean Journal of Hematology and Infectious Diseases.
Our work explores the emerging challenge of aging in patients with thalassemia and sickle cell disease, proposing a gerontological framework to better understand and manage the growing population of adults living beyond midlife with these conditions.
Key insights:
- Hemoglobinopathies are increasingly becoming lifelong chronic conditions, with more patients reaching their 50s and beyond
- There is a shift from acute, disease-centered care to managing multimorbidity and functional decline
- Clinical priorities should include frailty, cognition, quality of life, and patient-centered outcomes
- Multidisciplinary and integrated care models are essential for optimal long-term management
This work highlights the need to rethink traditional care models and align them with the realities of aging with complex chronic diseases.
Grateful to collaborate with such a dedicated multidisciplinary team.”
Title: Aging with thalassemia and sickle cell disease: A gerontological model of accelerated multimorbidity and function-centered care beyond midlife
Authors: Sophia Delicou, Ioannis Ilias, Athanasia Kapota, Elena Papatheodorou, Maria Moraki, Aikaterini Xydaki, Alexandra Mika, Panagiota Giannou, Irene Kouroukli, Theodoros Aforozis, Myrto Palkopoulou, Christos Savvidis, Iliana Mani, Constantina Aggeli, John Koskinas

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian